国产罗红霉素杂质谱及与合成工艺相关性评价

目的: 考察国产罗红霉素的杂质谱情况,并与合成工艺相关性进行初步评价。方法: 采用欧洲药典7.0版罗红霉素有关物质方法对国产样品进行分析,使用Waters Symmetry Shield^TM C₁₈ 色谱柱(150 mm×3.9 mm,5 μm),以0.52 mol · L^-1 磷酸二氢铵溶液[用氢氧化钠溶液(8.5→100)调节pH至4.3]-乙腈(74:26)为流动相A,以水-乙腈(30:70)为流动相B,梯度洗脱(0~50 min,100%A;50~51 min,100%A→90%A;51~80 min,90%A;80~81 min,90%A→100%A;81~100 min,100%A),色谱柱温15 ℃,自动进样器温度8 ℃,检测波长205 nm。以系统适用性对照品对11种已知杂质进行定位,以罗红霉素为外标计算杂质含量。结果: 国产罗红霉素中检出的主要杂质为杂质H、杂质F和杂质C。杂质H是影响国产罗红霉素质量的主要杂质。结论: 国产罗红霉素的主要杂质H和杂质F与合成工艺中起始反应物硫氰酸红霉素中红霉素B和去甲基红霉素的含量相关;杂质C为反应中间体红霉素(E)肟的残留,通过优化纯化工艺可降低杂质C的含量。国产罗红霉素的合成工艺可有效的去除侧链合成中引入的杂质G、杂质J和杂质K。

Objective: To investigate the impurity profile of domestic roxithromycin and evaluate the correlation between the impurity profile andthe synthesis technology. Methods: Using the EP 7.0 roxithromycin related substances method in the European Pharmacopoeia(version 7.0), the domestic samples were analyzed.A Waters Symmetry Shield^TM C₁₈ column(150 mm×3.9 mm, 5 μm)was used;the mobile phase A was the mixture of 0.52 mol · L^-1 ammonium dihydrogen phosphate solution[adjusted to pH 4.3 with sodium hydroxide solution(8.5→100)]-acetonitrile(74:26), the mobile phase B was the mixture of water-acetonitrile(70:30), eluting with a gradient program(0-50 min, 100%A;50-51 min, 100%A→90%A;51-80 min, 90%A;80-81 min, 90%A→100%A;81-100 min, 100%A).The column temperature was maintained at 15 ℃ and the injector temperature was maintained at 8 ℃, the detection wavelength was set at 205 nm.The 11 known impurities were located by injecting the roxithromycin system suitability standard.The contents of impurities were calculated using roxithromycin as an external standard. Results: The major impurities of domestic roxithromycin were impurities H, F and C.Impurity H was the main impurity influencing the quality of domestic roxithromycin. Conclusion: The contents of impurities H and F are related to the contents of erythromycin B and demethylerythromycin present in the initial reactant thiocyanate erythromycin.Impurity C is the residue of reaction intermediate erythromycin-9-(E)-oxime, the content of which can be reduced by optimizing the purification process.The synthesis technology of the domestic roxithromycin can effectively remove the impurities G, J and K induced in side-chain synthesis of roxithromycin.

[1] DAI H(戴红), HU CQ(胡昌勤).HPLC analysis of roxithromycin and its related substances(HPLC法分析罗红霉素及其片剂含量和相关杂质)[J].Chin J Pharm Anal(药物分析杂志), 2002, 22(3):185
[2] LI SH(李少华), WANG F(汪玢), TU JP(涂剑平), et al.The synthesis of roxithromycin(罗红霉素的合成)[J].Acta Acad Med Jiangxi(江西医学院学报), 1999, 39(3):13
[3] ZHI HJ(智会静), YOU QD(尤启冬).The research advancement and synthesis of ketolides(第三代大环内脂类抗生素的结构改造及合成方法)[J].Chin J Antibiot(中国抗生素杂志), 2011, 36(7):492
[4] ChP 2010.Vol Ⅱ(中国药典2010年版.二部)[S].2010:462
[5] YANG DZ(杨德智), XU WS(徐维盛), ZHANG L(张丽), et al.Optimizition of HPLC method of roxithromycin in Chinese Pharmacopoeia(优化《中国药典》罗红霉素HPLC含量测定方法研究)[J].China Pharm(中国药房), 2011, 22(17):1604
[6] EP 7.0[S].2011:2869
[7] LI W(李玮).Studies on the thermal kinetics of thermal decomposition and stability of macrolide drugs(大环内酯类抗生素热稳定性及分解动力学研究)[J].Chin J Pharm Anal(药物分析杂志), 2010, 30(8):1544
[8] LIAN ML(连苗利), JIN Y(金勇), WANG ZG(王兆刚), et al.Impurities control in the synthesis of roxithromycin(罗红霉素合成过程的杂质控制)[J].Fine Chem Intermed(精细化工中间体), 2010, 40(2):44
[9] MA CD(马昌东), XU H(徐鸿), LI XZ(李新柱), et al.Studies of the synthesis of roxithromycin(罗红霉素合成工艺研究)[J].China Pract Med(中国实用医药), 2011, 6(17):145
[10] YAN F(闫峰), MA ZQ(马忠青).An improved method for the synthesis of roxithromycin(罗红霉素合成工艺的改进)[J].Hebei Chem Ind(河北化工), 2006, 29(6):28
[11] HU GQ(胡国强), XU QJ(许秋菊), XU QT(许启泰), et al.An improved synthesis of roxithromycin by phase transfer catalyst(罗红霉素合成工艺改进)[J].Chin J Antibiot(中国抗生素杂志), 2004, 29(10):588
[12] CAO MC(曹孟婵), ZHANG BC(张部昌).Glycosyl synthesis and biofunction of macrolide antibiotics(大环内酯类抗生素糖基合成及生物学功能)[J].Chin J Antibiot(中国抗生素杂志), 2007, 32(3):140